Developer of drugs and diagnostics for cardiovascular diseases. The company's lead candidate is "Revacept", a therapeutic agent used to prevent and treat acute arterial thrombosis that can lead to heart attack and stroke. Also, it is developing GPVI-inhibiting antibodies to inhibit the attachment of platelets to the wall of a blood vessel.
← All startups
AdvanceCOR
Series ADeveloper of drugs and diagnostics for cardiovascular diseases. The company's lead candidate is "Revacept", a therapeutic agent used to prevent and treat acute arterial thrombosis that can lead to heart attack and stroke. Also, it is developing GPVI-inhibiting antibodies to inhibit the attachment of platelets to the wall of a blood vessel.
About
Institutional investors
MIG CapitalBayern KapitalKfwBioMHTGFFirst Capital PartnersOCCIDENTGlobal Chance FundMIG Fonds
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.